Skip to main content
SpringerLink
Log in

T Cell-Targeted Therapy for Rheumatoid Arthritis

  • Chapter
Immune Regulation and Immunotherapy in Autoimmune Disease

  • 742 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ablamunits, V., Quintana, F., Reshef, T., et al. (1999) Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J. Autoimmun. 13:383–392.

    Article  PubMed  CAS  Google Scholar 

  • Almawi, W. Y., Melemedjian, O. K., Rieder, M. J. (1999) An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin. Transplant. 13:365–374.

    Article  PubMed  CAS  Google Scholar 

  • Banerjee, S., Webber, C., Poole, A. R. (1992) The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell. Immunol. 144:347–357.

    Article  PubMed  CAS  Google Scholar 

  • Barrett, S. P., Toh, B. H., Alderuccio, F., et al. (1995) Organ-specific autoimmunity induced by adult thymectomy and cyclophosphamide-induced lymphopenia. Eur. J. Immunol. 25:238–244.

    Article  PubMed  CAS  Google Scholar 

  • Bessis, N., Boissier, M. C., Ferrara, P., et al. (1996) Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26:2399–2403.

    Article  PubMed  CAS  Google Scholar 

  • Breedveld, F. C., Dynesius-Trentham, R., de Sousa, M., Trentham, D. E. (1989) Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. Cell. Immunol. 121:1–12.

    Article  PubMed  CAS  Google Scholar 

  • Bruneau, J. M., Yea, C. M., Spinella-Jaegle, S., et al. (1998) Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. Biochem. J. 336:299–303.

    PubMed  CAS  Google Scholar 

  • Calin, A., Elswood, J., Klouda, P. T. (1989) Destructive arthritis, rheumatoid factor, and HLA-DR4: susceptibility versus severity, a case-control study. Arthritis Rheum. 32:1221–1225.

    Article  PubMed  CAS  Google Scholar 

  • Constantin, A., Loubet-Lescoulie, P., Lambert, N., et al. (1998) Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum. 41:48–57.

    Article  PubMed  CAS  Google Scholar 

  • De Groot, K., Gross, W. L. (1998) Wegener’s granulomatosis: disease course, assessment of activity and extent and treatment. Lupus 7:285–291.

    Article  PubMed  Google Scholar 

  • Dimitrova, P., Skapenko, A., Herrmann, M. L., et al. (2002) Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J. Immunol. 169:3392–3399.

    PubMed  CAS  Google Scholar 

  • Emmrich, F., Schulze-Koops, H., Burmester, G. (1994) Anti-CD4 and other antibodies to cell surface antigens for therapy. In: Immunopharmacology of Joints and Connective Tissue. London, Academic Press, pp 87–117.

    Google Scholar 

  • Firestein, G. S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361.

    Article  PubMed  CAS  Google Scholar 

  • Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4:330–336.

    Article  PubMed  CAS  Google Scholar 

  • Genovese, M. C., Becker, J. C., Schiff, M., et al. (2005) Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N. Engl. J. Med. 353:1114–1123.

    Article  PubMed  CAS  Google Scholar 

  • Gleeson, P. A., Toh, B. H., van Driel, I. R. (1996) Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 149:97–125.

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb, A. B. (2006) Alefacept for psoriasis and psoriatic arthritis. Ann. Rheum. Dis. 64:58–60.

    Google Scholar 

  • Hepburn, T. W., Totoritis, M. C., Davis, C. B. (2003) Antibody-mediated stripping of CD4 from lymphocyte cell surface in patients with rheumatoid arthritis. Rheumatology (Oxford) 42:54–61.

    Article  CAS  Google Scholar 

  • Joosten, L. A., Lubberts, E., Helsen, M. M., et al. (1999) Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1:81–91.

    Article  PubMed  CAS  Google Scholar 

  • Kang, B. Y., Chung, S. W., Im, S. Y., et al. (1999) Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages. Immunology 98:98–103.

    Article  PubMed  CAS  Google Scholar 

  • Kavanaugh, A. F., Davis, L. S., Nichols, L. A., et al. (1994) Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:992–999.

    Article  PubMed  CAS  Google Scholar 

  • Kavanaugh, A. F., Schulze-Koops, H., Davis, L. S., Lipsky, P. E. (1997). Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody. Arthritis Rheum. 40:849–853.

    Article  PubMed  CAS  Google Scholar 

  • Kojima, A., Prehn, R. T. (1981) Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14:15–27.

    Article  PubMed  CAS  Google Scholar 

  • Kremer, J. M., Westhovens, R., Leon, M., et al. (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349:1907–1915.

    Article  PubMed  CAS  Google Scholar 

  • Kremer, J. M., Dougados, M., Emery, P., et al. (2005) Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 52:2263–2271.

    Article  PubMed  CAS  Google Scholar 

  • Leung, B. P., Sattar, N., Crilly, A., et al. (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J. Immunol. 170:1524–1530.

    PubMed  CAS  Google Scholar 

  • Maksymowych, W. P., Blackburn, W. D., Jr., Tami, J. A., Shanahan, W. R., Jr. (2002) A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis. J. Rheumatol. 29:447–453.

    PubMed  CAS  Google Scholar 

  • Miltenburg, A. M., van Laar, J. M., de Kuiper, R., et al. (1992) T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand. J. Immunol. 35:603–610.

    Article  PubMed  CAS  Google Scholar 

  • Mizoguchi, A., Mizoguchi, E., Smith, R. N., et al. (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186:1749–1756.

    Article  PubMed  CAS  Google Scholar 

  • Mombaerts, P., Mizoguchi, E., Grusby, M. J., et al. (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274–282.

    Article  PubMed  CAS  Google Scholar 

  • Moreland, L. W., Alten, R., Van den Bosch, F., et al. (2002) Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 46:1470–1479.

    Article  PubMed  CAS  Google Scholar 

  • Morinobu, A., Wang, Z., Kumagai, S. (2000) Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism. J. Rheumatol. 27:851–858.

    PubMed  CAS  Google Scholar 

  • Patel, S., Veale, D., FitzGerald, O., McHugh, N. J. (2001) Psoriatic arthritis—emerging concepts. Rheumatology 40:243–246.

    Article  PubMed  CAS  Google Scholar 

  • Sadlack, B., Merz, H., Schorle, H., et al. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253–261.

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi, N., Miyai, K., Sakaguchi, S. (1994a) Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells. J. Immunol. 152:2586–2595.

    PubMed  CAS  Google Scholar 

  • Sakaguchi, S., Ermak, T. H., Toda, M., et al. (1994b) Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression. J. Immunol. 152:1471–1484.

    PubMed  CAS  Google Scholar 

  • Sakaguchi, S., Sakaguchi, N. (1989) Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J. Immunol. 142:471–480.

    PubMed  CAS  Google Scholar 

  • Sakaguchi, S., Sakaguchi, N., Asano, M., et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151–1164.

    PubMed  CAS  Google Scholar 

  • Schulze-Koops, H. (2004). Lymphopenia and autoimmune diseases. Arthritis Res. Ther. 6:178–180.

    Article  PubMed  CAS  Google Scholar 

  • Schulze-Koops, H., Kalden, J. R. (2003) Targeting T Cells in rheumatic diseases. In: Smolen, J. S., Lipsky, P. E. (eds) Biological Therapy in Rheumatology. London, Martin Dunitz, pp 3–24.

    Google Scholar 

  • Schulze-Koops, H., Lipsky, P. E. (2000) Anti-CD4 monoclonal antibody therapy in human autoimmune diseases. Curr. Dir. Autoimmun. 2:24–49.

    Article  PubMed  CAS  Google Scholar 

  • Schulze-Koops, H., Lipsky, P. E. (2004) T cells in the pathogenesis of rheumatoid arthritis. In: Clair, W. W., Pisetsky, D. S., Haynes A. (eds) Rheumatoid Arthritis. Philadelphia, Lippincott Williams & Wilkins, pp 184–196.

    Google Scholar 

  • Schulze-Koops, H., Lipsky, P. E., Kavanaugh, A. F., Davis, L. S. (1995). Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J. Immunol. 155:5029–5037.

    PubMed  CAS  Google Scholar 

  • Simon, A. K., Seipelt, E., Sieper, J. (1994) Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91:8562–8566.

    Article  PubMed  CAS  Google Scholar 

  • Skapenko, A., Wendler, J., Lipsky, P. E., et al. (1999) Altered memory T cell differentiation in patients with early rheumatoid arthritis. J. Immunol. 163:491–499.

    PubMed  CAS  Google Scholar 

  • Skapenko, A., Lipsky, P. E., Kraetsch, H. G., et al. (2001) Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J. Immunol. 166:4283–4292.

    PubMed  CAS  Google Scholar 

  • Utset, T. O., Auger, J. A., Peace, D., et al. (2002) Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J. Rheumatol. 29:1907–1913.

    PubMed  CAS  Google Scholar 

  • Wildin, R. S., Smyk-Pearson, S., Filipovich, A. H. (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39:537–545.

    Article  PubMed  CAS  Google Scholar 

  • Winchester, R. (1994) The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56:389–466.

    Article  PubMed  CAS  Google Scholar 

  • Yacyshyn, B. W., Chey, W., Salzberg, G. B., et al. (2000) Double-blinded, randomized, placebo-controlled trial of the remission inducing and steroid sparing properties of two schedules of ISIS 2302 (ICAM-1 antisense) in active, steroid-dependent Crohn’s disease. Gastroenterology 118:S2:2977.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nikolaus Fiebiger Centre for Molecular Medicine Clinical Research Group III, University of Erlangen-Nuremberg, Erlangen, Germany

    Hendrik Schulze-Koops

  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA

    Peter E. Lipsky

Authors
  1. Hendrik Schulze-Koops
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter E. Lipsky
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Shanghai JiaoTong University School of Medicine, Shanghai, China

    Jingwu Zhang M.D., Ph.D.

  2. Baylor College of Medicine, Houston, Texas, USA

    Jingwu Zhang M.D., Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Schulze-Koops, H., Lipsky, P.E. (2007). T Cell-Targeted Therapy for Rheumatoid Arthritis. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_18

Download citation

Publish with us

Policies and ethics

Search

Navigation